Envestnet Asset Management
JNP

Envestnet Asset Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Envestnet Asset Management’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1
Closed – – 3111
2018
Q2 		$0 Hold
1
– – ﹤0.01% 2932
2018
Q1 		$0 Hold
1
– – ﹤0.01% 3033
2017
Q4 		$0 Hold
1
– – ﹤0.01% 3047
2017
Q3 		$0 Sell
1
-1,000
-100% -$4.7K ﹤0.01% 3121
2017
Q2 		$5K Buy
1,001
+1,000
+100,000% +$4.47K ﹤0.01% 2850
2017
Q1 		$0 Hold
1
– – ﹤0.01% 3215
2016
Q4 		$0 Sell
1
-1,000
-100% -$5.49K ﹤0.01% 3453
2016
Q3 		$6K Hold
1,001
– – ﹤0.01% 2883
2016
Q2 		$7K Hold
1,001
– – ﹤0.01% 3047
2016
Q1 		$7K Buy
+1,001
New +$7.37K ﹤0.01% 3049

Envestnet Asset Management's JNP Position: Q3 2018 in Review

Envestnet Asset Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 1 share.

Envestnet Asset Management first reported a position in JNP in Q1 2016 and held it in 10 quarters. The position peaked at $7K in Q2 2016. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

  • Envestnet Asset Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Envestnet Asset Management sold 1 Juniper Pharmaceuticals, Inc. Common Stock share in Q3 2018.
  • Envestnet Asset Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q1 2016 and held it in 10 quarters.
  • Envestnet Asset Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $7K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Envestnet Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.